Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19. (2022)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202101200
PubMed Identifier: 35012962
Publication URI: http://europepmc.org/abstract/MED/35012962
Type: Journal Article/Review
Volume: 5
Parent Publication: Life science alliance
Issue: 4
ISSN: 2575-1077